News + Filings Transactions
|
Waksal Harlan
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/31/2023 | Lyra Therapeutics, Inc. | LYRA | Grant | Stock Option | 200k | $2.85 | $570k | | 01/31/2023 |
| 06/16/2022 | Lyra Therapeutics, Inc. | LYRA | Grant | Stock Option | 953k | $5.09 | $4.9M | | 06/16/2022 |
| 04/12/2022 | Lyra Therapeutics, Inc. | LYRA | Purchase | Common Stock | 237k | $4.22 | $1000k | | 04/12/2022 |
| 02/16/2022 | Lyra Therapeutics, Inc. | LYRA | Grant | Stock Option | 520k | $4.21 | $2.2M | | 02/16/2022 |
| 11/09/2021 | Kadmon Holdings, Inc. | KDMN | Disposition | Performance Stock Option(right to buy) | 982.5k | $4.06 | $4M | | 11/09/2021 |
| 11/09/2021 | Kadmon Holdings, Inc. | KDMN | Disposition | Stock Option (right to buy) | 1.4M | $4.15 | $5.6M | | 11/09/2021 |
| 11/09/2021 | Kadmon Holdings, Inc. | KDMN | Disposition | Stock Option (right to buy) | 2M | $3.96 | $7.9M | | 11/09/2021 |
| 11/09/2021 | Kadmon Holdings, Inc. | KDMN | Disposition | Equity Appreciation Rights Unit | 750 | $6.00 | $4.5k | | 11/09/2021 |
| 11/09/2021 | Kadmon Holdings, Inc. | KDMN | Disposition | Stock Appreciation Right | 655k | $3.64 | $2.4M | | 11/09/2021 |
| 11/09/2021 | Kadmon Holdings, Inc. | KDMN | Disposition | Common Stock | 177.9k | $9.50 | $1.7M | | 11/09/2021 |
| 05/13/2021 | Kadmon Holdings, Inc. | KDMN | Grant | Common Stock | 25k | $3.56 | $89k | | 05/13/2021 |
| 04/03/2021 | Kadmon Holdings, Inc. | KDMN | Grant | Performance Stock Option (right to buy) | 327.5k | $4.06 | $1.3M | | 04/03/2021 |
| 01/08/2021 | Kadmon Holdings, Inc. | KDMN | Grant | Stock Option (right to buy) | 2M | $3.96 | $7.9M | | 01/08/2021 |
| 09/10/2020 | Kadmon Holdings, Inc. | KDMN | Grant | Performance Stock Option (right to buy) | 109.2k | $4.06 | $443.2k | | 09/10/2020 |
| 03/13/2020 | Kadmon Holdings, Inc. | KDMN | Purchase | Common Stock, par value $0.001 | 16k | $2.93 | $46.8k | | 03/13/2020 |
| 03/11/2020 | Kadmon Holdings, Inc. | KDMN | Purchase | Common Stock, par value $0.001 | 12.6k | $3.96 | $49.9k | | 09/28/2018 |
| 11/19/2019 | Kadmon Holdings, Inc. | KDMN | Grant | Stock Option (right to buy) | 1.4M | $0.00 | $0 | | 11/19/2019 |
| 11/19/2019 | Kadmon Holdings, Inc. | KDMN | Grant | Stock Option (right to buy) | 1.4M | $4.14 | $5.6M | | 11/19/2019 |
| 10/24/2019 | Kadmon Holdings, Inc. | KDMN | Grant | Performance Stock Option (right to buy) | 109.2k | $4.06 | $443.2k | | 10/24/2019 |
| 09/10/2019 | Kadmon Holdings, Inc. | KDMN | Grant | Performance Stock Option (right to buy) | 109.2k | $4.06 | $443.2k | | 09/10/2019 |
| 06/14/2019 | Kadmon Holdings, Inc. | KDMN | Grant | Performance Stock Option (right to buy) | 109.2k | $4.06 | $443.2k | | 06/14/2019 |
| 04/03/2019 | Kadmon Holdings, Inc. | KDMN | Grant | Performance Stock Option (right to buy) | 218.3k | $4.06 | $886.4k | | 04/03/2019 |
| 03/29/2019 | Kadmon Holdings, Inc. | KDMN | Grant | | 7.7k | $2.25 | $17.4k | | 09/28/2018 |
| 09/28/2018 | Kadmon Holdings, Inc. | KDMN | Grant | | 5.9k | $2.84 | $16.7k | | 09/28/2018 |
| 12/08/2017 | Kadmon Holdings, Inc. | KDMN | Grant | Stock Appreciation Right | 655k | $3.64 | $2.4M | | 12/08/2017 |
| 08/10/2017 | Kadmon Holdings, Inc. | KDMN | Purchase | Common Stock, par value $0.001 | 5k | $2.27 | $11.3k | | 08/10/2017 |
| 08/08/2017 | Kadmon Holdings, Inc. | KDMN | Purchase | Common Stock, par value $0.001 | 3.7k | $2.34 | $8.7k | | 08/08/2017 |
| 11/16/2016 | Kadmon Holdings, Inc. | KDMN | Purchase | Common Stock, par value $0.001 | 2k | $6.37 | $12.7k | | 11/16/2016 |
| 11/14/2016 | Kadmon Holdings, Inc. | KDMN | Purchase | Common Stock, par value $0.001 | 2k | $6.79 | $13.6k | | 11/14/2016 |
| 09/13/2013 | Eloxx Pharmaceuticals, Inc. | ELOX | Grant | Common Stock Option | 530k | $0.05 | $28.6k | | 09/13/2013 |
| 09/13/2013 | Eloxx Pharmaceuticals, Inc. | ELOX | Grant | Common Stock Option | 530k | $0.05 | $28.6k | | 09/13/2013 |
| 05/17/2013 | Eloxx Pharmaceuticals, Inc. | ELOX | Grant | Common Stock Option | 273.3k | $0.04 | $11.8k | | 05/17/2013 |
| 02/19/2013 | Eloxx Pharmaceuticals, Inc. | ELOX | Grant | Common Stock Option | 145.8k | $0.13 | $19.3k | | 02/19/2013 |
| 11/16/2012 | Eloxx Pharmaceuticals, Inc. | ELOX | Grant | Common Stock Options | 420k | $0.17 | $69.3k | | 11/16/2012 |
| 11/16/2012 | Eloxx Pharmaceuticals, Inc. | ELOX | Grant | Common Stock Options | 165.2k | $0.17 | $27.3k | | 11/16/2012 |
|
|